surpass trial tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 SURPASS to SURMOUNT: The Tirzepatide

A plant-based meal stimulates incretin and insulin secretion more than an energy- and macronutrient-matched standard meal in type 2 diabetes: a randomized crossover study

Monitoring patient progress and side effects The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) guidelines recommend that patients receiving treatments for obesity be evaluated every 4-12 weeks

Your Restoration MedSpa provider is dedicated to providing the information you need to make the most informed decisions about your well-being

An extra tablespoon of olive oil while cooking (120 calories)

You can pay as little as $25 for 1, 2, or 3-month supply

Going off Zepbound will end its benefits